Results 61 to 70 of about 1,019,184 (189)
Rivastigmine and QT interval prolongation [PDF]
British Journal of Psychiatry, 2003 Walsh & Dourish ( [2002][1]) reported that a 78-year-old man, receiving a number of medications and with a history of myocardial infarction and hypokalaemia, developed an abnormal QTc interval a week after starting rivastigmine treatment.
openaire +1 more source
QT Measurement and Heart Rate Correction during Hypoglycemia: Is There a Bias?
Cardiology Research and Practice, 2010 Introduction. Several studies show that hypoglycemia causes QT interval prolongation. The aim of this study was to investigate the effect of QT measurement methodology, heart rate correction, and insulin types during hypoglycemia. Methods.
Toke Folke Christensen +5 more
doaj +1 more source
Drug induced QT interval prolongation
, 2019 QT interval je elektrokardiografska manifestacija ventrikulske depolarizacije i repolarizacije posredovana ionskim kanalima čija je duljina određena dobi, spolom i frekvencijom srca, a kao referentne vrijednosti uzimaju se duljine 360-390 ms kod ...
Bračko, Dora
core +1 more source
Identification of patients at-risk of QT interval prolongation during medication reviews: a missed opportunity? [PDF]
, 2018 The prolongation of the QT interval is a relatively rare but serious adverse drug reaction. It can lead to torsade de pointes, which is potentially life-threatening.
Lee, K (14794306) +4 more
core +2 more sources
[Drug induced QT prolongation]
, 2008 Prolongation of the ventricular repolarisation manifests itself as a prolongation of the QT intervall on the surface ECG and represents a major risk for a special form of ventricular tachycardia called "torsades de pointes". Torsades de pointes are often
Altmann, D., Eggmann, U., Ammann, P.
core +2 more sources
Journal of Pharmacological Sciences, 2005 Potential utility of halothane-anesthetized guinea pigs for detecting drug-induced repolarization delay was analyzed in comparison with urethane-anesthesia (n = 4 for both groups).
Yasue Sakaguchi +5 more
doaj +1 more source
Kidney & Blood Pressure Research, 2017 Background/Aims: Hemodialysis patients have poor prognosis due to increased prevalence of cardiovascular diseases. Treatment to suppress increases in sympathetic nerve activity and QT prolongation may have the potential to reduce the occurrence of these ...
Takeshi Iida +4 more
doaj +1 more source
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients
Scientific Reports, 2020 SARS-CoV-2 is a rapidly evolving pandemic causing great morbimortality. Medical therapy with hydroxicloroquine, azitromycin and protease inhibitors is being empirically used, with reported data of QTc interval prolongation.
Juan Jiménez-Jáimez +12 more
doaj +1 more source
Drug- and non-drug-associated QT interval prolongation
, 2010 Sudden cardiac death is among the most common causes of cardiovascular death in developed countries. The majority of sudden cardiac deaths are caused by acute ventricular arrhythmia following repolarization disturbances.
Stricker, B.H.Ch. (Bruno) +5 more
core +1 more source
Drug-induced QT interval prolongation and adverse cardiac events: a scoping review
, 2020 QT interval prolongation is commonly used a surrogate marker for arrhythmogenic and torsadogenic risk, however the relationship between medications associated with QT prolongation, drug-induced QT-prolongation, and adverse cardiac outcomes, remains ...
Michael Cristian Garcia
core +1 more source